These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3062528)

  • 1. Prophylactic treatment of intraocular pressure elevations after neodymium: YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol.
    Silverstone DE; Novack GD; Kelley EP; Chen KS
    Ophthalmology; 1988 Jun; 95(6):713-8. PubMed ID: 3062528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Rakofsky S; Koch DD; Faulkner JD; Terry SA; Mandell AI; Gross RL; Kelley EP; Iacono TL; Lue J
    J Cataract Refract Surg; 1997 Sep; 23(7):1075-80. PubMed ID: 9379380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy.
    Yeom HY; Lee JH; Hong YJ; Seong GJ
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):176-81. PubMed ID: 16808678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG laser posterior capsulotomy.
    Brown SV; Thomas JV; Belcher CD; Simmons RJ
    Ophthalmology; 1985 Mar; 92(3):354-9. PubMed ID: 3991123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term elevation of intraocular pressure after neodymium: YAG laser posterior capsulotomy.
    Jahn CE; Emke M
    Ophthalmologica; 1996; 210(2):85-9. PubMed ID: 9148259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nd:YAG laser posterior capsulotomy does not produce elevation of intraocular pressure in cynomolgus monkeys.
    Camras CB; Rosenthal JS; Podos SM
    Ophthalmic Surg; 1988 Jun; 19(6):403-7. PubMed ID: 3419775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of Nd:YAG laser capsulotomy after cataract surgery in Olmsted County, Minnesota.
    Baratz KH; Cook BE; Hodge DO
    Am J Ophthalmol; 2001 Feb; 131(2):161-6. PubMed ID: 11228290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure after neodymium:YAG laser treatments in the anterior segment.
    Shani L; David R; Tessler Z; Rosen S; Schneck M; Yassur Y
    J Cataract Refract Surg; 1994 Jul; 20(4):455-8. PubMed ID: 7932138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies.
    Silverstone DE; Brint SF; Olander KW; Taylor RB; McCarty GR; deFaller JM; Burk LL
    Am J Ophthalmol; 1992 Apr; 113(4):401-5. PubMed ID: 1348396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy.
    Cai JP; Cheng JW; Wei RL; Ma XY; Jiang F; Zhu H; Li Y
    Int Ophthalmol; 2008 Feb; 28(1):19-22. PubMed ID: 17585375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the neodymium YAG laser following posterior chamber lens implantation].
    Radda TM; Gnad HD; Freyler H
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):427-9. PubMed ID: 4087803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical clonidine.
    Loewenstein A; Varssano D; Lazar M; Geyer O
    Acta Ophthalmol (Copenh); 1991 Aug; 69(4):462-5. PubMed ID: 1750315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nd:YAG laser posterior capsulotomy after pediatric and adult cataract surgery.
    Cinal A; Demirok A; Yasar T; Yazicioglu A; Yener HI; Kiliç A
    Ann Ophthalmol (Skokie); 2007; 39(4):321-6. PubMed ID: 18025654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nd:YAG laser posterior capsulotomy: a clinical study.
    Axt JC
    Am J Optom Physiol Opt; 1985 Mar; 62(3):173-87. PubMed ID: 3838621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy.
    Richter CU; Arzeno G; Pappas HR; Arrigg CA; Wasson P; Steinert RF
    Arch Ophthalmol; 1985 Jul; 103(7):912-5. PubMed ID: 3839390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.